IBRANCE® (palbociclib)

1. IBRANCE^® Summary of Product Characteristics.
2. DeMichele A, et al. Breast Cancer Res 2021;23:37
3. Rugo H, et al. Breast Cancer Res Treat. 2019;174(3):719-729.
4. Finn RS, et al. N Engl J Med. 2016;375(20):1925-1936.
5. Turner NC, et al. SABCS 2016; poster P4-22-06.

©2020 Pfizer. All rights reserved. PP-IBR-IRL-0501 Date of Preparation: March 2022 Legal Category: S1A